Patents Represented by Attorney Gabriel Lopez
  • Patent number: 6083521
    Abstract: This invention provides pharmaceutical compositions comprising polymeric matrices, especially those comprising IL-6 as an active ingredient. Specific novel poly(ethylene carbomate) polymers are also provided for more general use as matrix materials in sustained release compositions containing pharmacologically active compounds, as are methods of using of IL-6 for treatment of conditions mediated by IL-1 and/or TNF.alpha., e.g., certain autoimmune and inflammatory conditions, as well as septic shock.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: July 4, 2000
    Assignee: Novartis AG
    Inventors: Murat Acemoglu, Siegfried Bantle, David Bodmer, Salvatore Cammisuli, Peter Hiestand, Fritz Nimmerfall, Georg Stoll
  • Patent number: 6078705
    Abstract: The invention relates to a sensor platform based on at least two planar, separate, inorganic dielectric waveguiding regions on a common substrate and to a method for the parallel evanescent excitation and detection of the luminescence of identical or different analytes. The invention relates also to a modified sensor platform that consists of the sensor platform having the planar, separate, inorganic dielectric waveguiding regions and one or more organic phases immobilised thereon. A further subject of the invention is the use of the sensor platform or of the modified sensor platform in a luminescence detection method for quantitative affinity sensing and for the selective quantitative determination of luminescent constituents of optically opaque solutions.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: June 20, 2000
    Assignee: Novartis AG
    Inventors: Dieter Neuschafer, Gert Ludwig Duveneck, Michael Pawlak, Uwe Pieles, Wolfgang Budach
  • Patent number: 6047495
    Abstract: Spraying tubes (20 . . . ) through each of which a plurality of spraying holes are perforated along the longitudinal axis of each tube are placed in prescribed positions upper than feces boards (10 . . . ) of henhouses; and the spraying tubes (20 . . . ) are connected to agent-supplying means for supplying an agent such as a tank, a pump, etc. and airsupplying means for supplying compressed air such as a compressor, etc. The spraying holes make an angle not smaller than 5 degrees and not greater than 90 degrees as measured downward from the horizontal plane at the time of spraying an agent, in order to make it possible to spray the agent to feces boards (10 . . . ) and feces floor (12). The eggs of pests such as housefly and the like laid on the feces adhering to the feces boards and feces floor can efficiently and certainly be controlled.
    Type: Grant
    Filed: December 11, 1996
    Date of Patent: April 11, 2000
    Assignee: Novartis Corporation
    Inventors: Syunji Matsumura, Isao Takada, Toshiaki Mima, Kazuo Fukui
  • Patent number: 6032073
    Abstract: A transdermal system (1) for the administration of at least two substances through the skin with the aid of an electric current has a reservoir, which comprises a storage layer (2) for the substances, and a transfer means, which may be arranged in the form of a separating layer (3), that is connected to both the reservoir and the patient's skin (5) during administration. The transdermal system also has electrodes (4) which generate a current that transports the substances from the reservoir into the skin (5). In the transdermal system (1) means for the physical separation of the substances are provided that render possible a sequential administration of the substances.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: February 29, 2000
    Assignee: Novartis AG
    Inventor: Carlo Stefan Effenhauser
  • Patent number: 6017851
    Abstract: The invention relates to an herbicidal composition comprising N-[2-(3,3,3-trifluoropropyl)-phenylsulfonyl]-N'-(4-methoxy-6-methyl-1,3,5- triazin-2-yl)-urea or an agrochemically tolerated salt thereof, and a synergistic amount of an herbicide which is 3,5-dibromo-4-hydroxybenzonitrile or 3,6-dichloro-2-methoxybenzoic acid.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: January 25, 2000
    Assignee: Novartis Corp.
    Inventors: Hans Gut, Wolfgang Paul Iwanzik, Martin Schulte
  • Patent number: 6015919
    Abstract: The invention relates to a compound of formula I ##STR1## R.sub.1 is C.sub.1 -C.sub.8 alkyl, phenyl or phenyl substituted by from 1 to 3 C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy substituents;R.sub.2 and R.sub.3 are each independently of the other hydrogen or C.sub.1 -C.sub.12 alkyl; andHal is F, Cl, Br or I.Compounds of formula I are valuable intermediates for compounds of formula III which are also a subject of this invention: ##STR2## R.sub.1, R.sub.2, R.sub.3 and Hal are as defined above; R.sub.10 and R.sub.11 are identical or different and are C.sub.1 -C.sub.12 alkyl, C.sub.5 -C.sub.12 cycloalkyl, phenyl, C.sub.5 -C.sub.12 cycloalkyl substituted by C.sub.1 -C.sub.4 alkyl or by C.sub.1 -C.sub.4 alkoxy, or phenyl substituted by from one to three C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, --SiR.sub.4 R.sub.5 R.sub.6, halogen, --SO.sub.3 M, --CO.sub.2 M, --PO.sub.3 M, --NR.sub.7 R.sub.8, --[.sup.+ NR.sub.7 R.sub.8 R.sub.9 ]X.sup.- or C.sub.1 -C.sub.5 fluoroalkyl substituents; orthe group --PR.
    Type: Grant
    Filed: February 8, 1999
    Date of Patent: January 18, 2000
    Assignee: Novartis AG
    Inventor: Benoit Pugin
  • Patent number: 6011149
    Abstract: The present invention relates to photochemically cross-linked derivatives of general formulae (IA) and (IB), wherein R is a polysaccharide radical in which the OH groups have been esterified as OR' groups or converted into a carbamate (urethane), R.sub.1, and R.sub.2 are each independently lower alkyl or unsubstituted or substituted aryl, X is a direct bond or phenylene, m is 0 or 1, and n is 0 or an integer from 1 to 20, to processes from the preparation thereof and to the use thereof. The compounds of general formula (IA) and (IB) can be used as supports in the chromatographic separation of enantiomers.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: January 4, 2000
    Assignee: Novartis AG
    Inventor: Eric Francotte
  • Patent number: 6008393
    Abstract: Compounds of formulae I: (DIP)IrX.sub.q Y.sub.r (Z), Ia: (DIP)IrX.sub.s Y.sub.t (Z).sub.2 and Ib: (DIP)Ir(Z).sub.3 or mixtures of at least two of those compounds, wherein DIP is a ditertiary diphosphine, the two phosphine groups of which are bonded to a C.sub.2 -, C.sub.3 - or C.sub.4 -carbon chain, with the result that the diphosphine forms a 5- to 7-membered ring together with the Ir atom, X is Cl, Br or I, Y is a hydrogen atom, q and r are 0, 1 or 2 and the sum of q+r is 2, s and t are 0 or 1 and the sum of s+t is 1, and Z is the anion of an organic oxy acid that contains a group C(.dbd.O), S(.dbd.O)O or P(.dbd.O)O in the anion. The compounds are excellent catalysts for the hydrogenation of imines, especially for the enantioselective hydrogenation of prochiral imines.
    Type: Grant
    Filed: January 22, 1998
    Date of Patent: December 28, 1999
    Assignee: Novartis AG
    Inventors: Rafael Sablong, John Anthony Osborn, Felix Spindler
  • Patent number: 6005084
    Abstract: Fibre-reactive asymmetrical triphenodioxazine compounds conform to the formula I ##STR1## where the individual symbols are as defined in the description, and mixtures thereof and are present in the form of a free acid or as salt. They are used as reactive dyes for dyeing or printing hydroxyl-containing or nitrogenuos organic substrates, such as leather or fiber material consisting of or comprising natural or synthetic polyamides or natural or regenerated cellulose; the most preferred substrate is textile material consisting of or comprising cotton.
    Type: Grant
    Filed: August 15, 1996
    Date of Patent: December 21, 1999
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Detlef Kalweit, Roland Wald
  • Patent number: 6005001
    Abstract: Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful delivery systems.
    Type: Grant
    Filed: October 29, 1998
    Date of Patent: December 21, 1999
    Assignee: Novartis AG (formerly Sandoz AG)
    Inventors: Friedrich Richter, Michel Steiger
  • Patent number: 5985890
    Abstract: Rapamycin derivatives selected among 32(S)-dihydro-rapamycin derivatives and 32-deoxo-rapamycin compounds. Rapamycin derivatives are disclosed of the formula: ##STR1## wherein the variables are in the specification.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: November 16, 1999
    Assignee: Novartis Ag
    Inventors: Sylvain Cottens, Richard Sedrani
  • Patent number: 5985321
    Abstract: Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a migrateable solvent such as 1,2-propyleneglycol as a solvent in the capsule filling and in the capsule shell. The manufacture of said capsules is improved, if in the process for making the soft gelatin capsules the gelatin bands are cooled with a liquid, and preferably with water.
    Type: Grant
    Filed: April 29, 1997
    Date of Patent: November 16, 1999
    Assignees: Novartis AG, R.P. Scherer GmbH
    Inventors: Werner Brox, Armin Meinzer, Horst Zande
  • Patent number: 5981582
    Abstract: When used in admixture with mancozeb, chlorothalonil, a copper salt, folpet, fluazinam or cymoxanil (it being possible for the latter to be used also together with one of the other five components), metalaxyl having a high R-enantiomer content of more than 70% by weight, or pure R-metalaxyl, exhibits a markedly increased fungicidal action against plant diseases as compared with a similar mixture in which metalaxyl is used in the form of the racemate.
    Type: Grant
    Filed: September 9, 1998
    Date of Patent: November 9, 1999
    Assignee: Novartis Corporation
    Inventors: Cosima Nuninger, John Edward Nicholas Goggin, Dino Sozzi
  • Patent number: 5981479
    Abstract: It has been found that nonimmunosuppressive, cyclophilin-binding cyclosporins are useful in the treatment and prevention of AIDS and AIDS-related disorders. Such cyclosporins include novel Ciclosporin derivatives modified at the 4- and/or 5-positions.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: November 9, 1999
    Assignee: Novartis AG
    Inventors: Soo Young Ko, Hans Kobel, Brigitte Besemer-Rosenwirth, Dieter Seebach, Rene P. Traber, Roland Wenger, Pietro Bollinger
  • Patent number: 5976417
    Abstract: A composition, suitable for stabilizing a polymeric composition against the effects of light, comprisinga) an N-acylated 2,2,6,6-tetraalkylpiperidinyl group (hereinafter N-acylated HALS) containing compound; andb) an N-oxy-subst. 2,2,6,6-tetraalkylpiperidinyl group (hereinafter N-oxy-substituted HALS) containing compound.A further aspect of the invention relates to a composition, suitable for stabilizing a polymeric composition against the effects of light, comprisinga) an N-acylated 2,2,6,6-tetraalkylpiperidinyl-group-containing compound in which a spiro group is attached in the 4-position (hereinafter defined as component i); andb) an N-acylated 2,2,6,6-tetraalkylpiperidinyl-group-containing compound in which in the 4-position no spiro group is present (hereinafter defined as component ii).These compounds are suitable as light stabilizers in acid catalyzed lacquer system.
    Type: Grant
    Filed: March 30, 1995
    Date of Patent: November 2, 1999
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Karl Bechtold, Gilbert Ligner, Rainer Wolf
  • Patent number: 5977182
    Abstract: Compounds of formula (I), wherein Y is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, OH, CN, NO.sub.2, Si(CH.sub.3).sub.3, CF.sub.3 or halogen, and T is a group (a) or (b), and wherein the remaining substituents have the following definitions: X is O, S or NR.sub.13 ; A is O or NR.sub.4 ; R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl, halo-C.sub.1 -C.sub.4 alkyl, cyclopropyl, C.sub.1 -C.sub.4 alkoxymethyl, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio or cyano; R.sub.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 cycloalkyl, cyano unsubstituted or substituted C.sub.1 -C.sub.6 alkoxycarbonyl, unsubstituted or substituted di(C.sub.1 -C.sub.6 alkyl)aminocarbonyl, unsubstituted or substituted C.sub.1 -C.sub.6 alkyl-S(O).sub.q, unsubstituted or substituted aryl-S(O).sub.q, unsubstituted or substituted heteroaryl, unsubstituted or substituted heterocyclyl, unsubstituted or substituted heterocyclylcarbonyl or unsubstituted or substituted phenyl; and R.sub.
    Type: Grant
    Filed: May 1, 1997
    Date of Patent: November 2, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Rene Zurfluh, Hugo Ziegler, Stephan Trah
  • Patent number: 5965716
    Abstract: A salt of formula IF.sub.n.A (I)in which F is the residue of a metal free anionic dyestuff having 1 to 4 acids groups,n is 1 to 2; andA is a group containing 1 to 4 sterically hindered amine groups and at least n ammonium or immonium groups.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: October 12, 1999
    Assignee: Clariant Finance (BVI) Limited
    Inventors: Bansi Lal Kaul, Angelos-Elie Vougioukas
  • Patent number: 5955484
    Abstract: Plant-protecting active ingredient mixtures having synergistically enhanced action, wherein component I is a compound having plant-immunising action of formula I ##STR1## wherein Z is CN, COOH or a salt thereof, CO--OC.sub.1 -C.sub.4 alkyl or CO--SC.sub.1 -C.sub.4 alkyl;and wherein component II is a compound selected from the groupA) 4-?3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl!morpholine ("dimethomorph");B) 5-methyl-1,2,4-triazolo?3,4-b!?1,3!benzothiazole ("tricyclazole"); andC) 3-allyloxy-1,2-benzothiazole-1,1-dioxide ("probenazole").
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: September 21, 1999
    Assignee: Novartis Finance Corporation
    Inventor: Wilhelm Ruess
  • Patent number: 5951971
    Abstract: An ophthalmic composition particularly in the form of eye-drops suitable for the treatment of diseases of the eye and surrounding areas. The composition contains a cyclosporin and a surfactant selected from polyoxyethylene fatty acid esters, polyoxyethylene alkylphenyl ethers and polyoxyethylene alkyl ethers, or mixtures thereof.
    Type: Grant
    Filed: December 17, 1996
    Date of Patent: September 14, 1999
    Assignee: Novartis AG
    Inventors: Yoichi Kawashima, Mitsuaki Kuwano
  • Patent number: 5945437
    Abstract: Plant-protecting mixtures of active ingredients having a synergistically increased action, wherein component I is a compound having a plant-immunizing action of the formula I ##STR1## in which Z is CN, COOH or a salt thereof, CO--OC.sub.1 -C.sub.4 alkyl or CO--SC.sub.1 -C.sub.4 alkyl;and wherein component II is a compound selected from the group consisting of propiconazole, difenoconazole, penconazole, fenpropimorph, fenpropidine, cyprodinil, metalaxyl, R-metalaxyl and pyroquilon.
    Type: Grant
    Filed: July 16, 1997
    Date of Patent: August 31, 1999
    Assignee: Novartis Finance Corporation
    Inventors: Wilhelm Ruess, Gertrude Knauf-Beiter, Ruth Beatrice Kung, Helmut Kessmann